Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;35(4):533-541.
doi: 10.1007/s00467-019-04454-w. Epub 2020 Jan 10.

Proteinuria-take a closer look!

Affiliations
Review

Proteinuria-take a closer look!

Arend Bökenkamp. Pediatr Nephrol. 2020 Apr.

Abstract

Proteinuria is a hallmark of kidney disease. Therefore, measurement of urine protein content plays a central role in any diagnostic work-up for kidney disease. In many cases, proteinuria analysis is restricted to the measurement of total protein content knowing that very high levels of proteinuria (nephrotic proteinuria) are characteristic of glomerular disease. Still, proteinuria can also be a manifestation of impaired tubular protein reabsorption or even be physiological. This review will discuss the physiology of renal protein handling and give guidance on a more sophisticated analysis of proteinuria differentiating albumin, low-molecular weight proteins and immunoglobulins. These non-invasive tests are available in most routine clinical laboratories and may guide the clinician in the diagnostic process before ordering far more expensive (molecular genetic testing) and/or invasive (kidney biopsy) diagnostics.

Keywords: Acute kidney injury; Glomerular disease; Low molecular weight proteins; Proteinuria; Selectivity; Tubulointerstitial disease.

PubMed Disclaimer

Conflict of interest statement

The author declares that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Estimated glomerular sieving coefficients for 12 plasma proteins versus molecular weight. Abbreviations: ß2m, ß2-microglobulin; RBP, retinol-binding protein; α1m, α1-microglobulin; TSH, thyroid-stimulating hormone; ß2GI, ß2-glycoprotein-I; ZAG, zinc-α2-globulin; α1AG, α1-acid glycoprotein; DBP, vitamin D-binding protein; TTR, transthyretin; ALB, albumin; TRF, transferrin; IgG, immunoglobulin G. From Norden et al. [15], reproduced with permission
Fig. 2
Fig. 2
Absorption and intra-cellular handling of LMW proteins in the proximal tubule. Megalin is present on the cell surface in high abundance. When low-molecular-weight proteins bind to megalin, this “cargo” is internalized into the early endosome. The endosome is acidified by the action of H+ATPase in concert with chloride channel 5 (CLCN5). At low pH, the cargo dissociates from megalin and passes through the late endosome and on to the lysosome where it is degraded. Megalin returns from the early endosome back to the surface of the cell, where it is available for internalization of more cargo. From Guggino [16], reproduced with permission
Fig. 3
Fig. 3
Simultaneous changes of the urinary cystatin C-creatinine ratio and the protein-creatinine ratio. Paired measurement of patients during the active phase (A) and in remission of minimal change nephropathy (B). Data presented as mean ± SD. From Herget-Rosenthal et al. [18], reproduced with permission
Fig. 4
Fig. 4
Albumin concentration along the nephron. Data calculated from a rat fractional micropuncture study. Arrows indicate the percentage of ultrafiltrated albumin which is reabsorbed in the respective nephron segment. From Tojo et al. [17], reproduced with permission
Fig. 5
Fig. 5
Histological diagnosis and urine albumin/protein ratio. A urine albumin/creatinine ratio (uAPR) value of 0.4 (dotted line) demonstrates a clear distinction between tubulointerstitial disorders and glomerular disorders. uPEI, urine protein electrophoresis and immunofixation; ATN, acute tubular necrosis; DN, diabetic nephropathy; Fib, fibrillary glomerulonephritis; FGS, focal segmental glomerulosclerosis; HT, hypertensive nephrosclerosis; IgA, IgA nephropathy; LC, light chain deposition disease; LN, lupus nephritis; MC, minimal change disease; MCGN, mesangiocapillary glomerulonephritis; MPGN, mesangioproliferative glomerulonephritis; MN, membranous nephropathy; MyCN, myeloma cast nephropathy; NGN, necrotizing glomerulonephritis; NGNC, necrotizing glomerulonephritis with crescents; TIN, tubulointerstitial nephritis; TMA, thrombotic microangiopathy. From Smith et al. [71], reproduced with permission

Similar articles

Cited by

References

    1. KDIGO (2013) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl:1–150
    1. Preston R, Naylor RW, Stewart G, Bierzynska A, Saleem MA, Lowe M, Lennon R (2019) A role for OCRL in glomerular function and disease. Pediatr Nephrol. 10.1007/s00467-019-04317-4 - PMC - PubMed
    1. Beara-Lasic L, Cogal A, Mara K, Enders F, Mehta RA, Haskic Z, Furth SL, Trachtman H, Scheinman SJ, Milliner DS, Goldfarb DS, Harris PC, Lieske JC, investigators of the Rare Kidney Stone Consortium (2019) Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts. Pediatr Nephrol. 10.1007/s00467-019-04210-0 - PMC - PubMed
    1. Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang LX, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A, CKD Prognosis Consortium Relationship of estimated GFR and albuminuria to concurrent laboratory abnormalities: an individual participant data meta-analysis in a global consortium. Am J Kidney Dis. 2019;73:206–217. - PMC - PubMed
    1. Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, Chan TM, Hou FF, Lewis JB, Locatelli F, Praga M, Schena FP, Levey AS, Inker LA, Chronic Kidney Disease Epidemiology Collaboration Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol. 2019;7:128–139. - PubMed